Tango Therapeutics
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $53,811 | $3,181 | $5,392 |
Gross Profit | -479 | 53,256 | 2,556 | 5,392 |
EBITDA | -41,385 | 16,429 | -38,193 | -41,908 |
EBIT | -41,864 | 15,874 | -38,818 | -42,530 |
Net Income | -38,749 | 15,884 | -38,853 | -39,876 |
Net Change In Cash | 0 | 53,811 | 3,181 | 5,392 |
Free Cash Flow | -29,940 | -31,103 | -37,143 | -41,748 |
Cash | 112,279 | 58,338 | 39,272 | 58,432 |
Basic Shares | 116,166 | 110,966 | 110,540 | 110,301 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $62,384 | $42,069 | $36,527 | $24,860 |
Gross Profit | 60,103 | 42,069 | 36,527 | 24,860 |
EBITDA | -109,008 | -143,096 | -111,758 | -109,463 |
EBIT | -111,289 | -145,595 | -114,173 | -111,071 |
Net Income | -101,594 | -130,302 | -101,744 | -108,176 |
Net Change In Cash | 62,384 | 42,069 | 36,527 | 24,860 |
Cost of Revenue | -81,066 | |||
Free Cash Flow | -139,934 | -132,255 | -119,508 | -116,772 |
Cash | 112,279 | 69,530 | 66,385 | 59,968 |
Basic Shares | 116,166 | 109,226 | 94,572 | 87,820 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$0.29 |
2025-09-30 | -$0.14 |
2025-06-30 | -$0.35 |
